U.S. market Closed. Opens in 7 hours 50 minutes

CTKB | Cytek Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue193.01M164.04M127.95M92.84M57.88M
Cost of Revenue83.59M63.06M48.81M41.13M29.21M
Gross Profit109.43M100.97M79.14M51.71M28.67M
Operating Expenses135.77M102.78M69.98M38.05M25.91M
Selling, General & Admin91.62M67.92M45.53M24.36M16.98M
Research & Development44.15M34.86M24.44M13.69M8.93M
Other Operating Expenses7.79M1.02M-1.53M994.00K252.00K
Operating Income-26.34M-1.83M6.45M13.66M3.73M
Other Expenses / Income10.64M3.09M-499.00K771.00K-20.02M
Before Tax Income-15.71M1.26M5.95M14.43M-16.29M
Income Tax Expenses-3.56M-1.22M1.50M-4.98M533.00K
Net Income-12.15M2.58M4.42M19.41M-16.83M
Interest Expenses2.07M2.57M1.74M333.00K1.00K
Basic Shares Outstanding135.28M134.51M133.75M132.99M132.99M
Diluted Shares Outstanding135.28M138.56M133.75M132.99M132.99M
EBITDA-17.11M3.83M7.69M15.37M4.04M
EBITDA Margin-8.87%2.34%6.01%16.55%6.97%
EBIT-13.64M3.92M7.66M14.76M-16.29M
EBIT Margin-7.07%2.39%5.99%15.90%-28.15%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙